Strong Evidence Emerging That Gut Microbiome Is a Key Variable in Immunotherapy Efficacy – Medscape
Medscape |
Strong Evidence Emerging That Gut Microbiome Is a Key Variable in Immunotherapy Efficacy
Medscape "I want to convince you that the microbiome can actually dictate the cancer immune set-point," said Laurence Zitvogel, MD, PhD, group leader, Tumor Immunology and Immunotherapy, Institut Gustave Roussy, Villejuif, France. As one of the scientists who … |
